DataMEDS AI Agrees to Acquire TBIA Cancer AI Blood Test Platform
DataMEDS AI agreed to acquire the TBIA cancer AI blood test platform from the Todos Medical estate for its subsidiary Helomics, Inc.
DataMEDS AI agreed to acquire the TBIA cancer AI blood test platform from the Todos Medical estate for its subsidiary Helomics, Inc.